Rang	Name	Position
1	Mr. Hadar Levy	Chief Executive Officer
2	Dr. David Zacut M.D.	Co-Founder & Vice-Chairman
3	Prof. Abraham Zangen Ph.D.	Co-Founder, Member of Scientific Advisory Board & Director
4	Mr. Ido Marom	Chief Financial Officer
5	Dr. Colleen Hanlon Ph.D.	Vice President of Medical Affairs
6	Mr. Michael Cohen	Vice President of US Sales
7	Dr. Yiftach Roth Ph.D.	Founder & Chief Scientific Officer
8	Mr. Dor Hagai	Vice President of Operations
9	Mr. Gilead Moiseyev Ph.D.	Chief Technology Officer
10	Mr. Menachem C. Klein Esq.	VP, General Counsel & Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Valor Management LLC	13,24%	60,62 Mio. USD
2	Masters Capital Management LLC	3,74%	17,11 Mio. USD
3	Acadian Asset Management LLC	2,01%	9,21 Mio. USD
4	Essex Investment Management Company, LLC	1,48%	6,76 Mio. USD
5	Renaissance Technologies Corp	1,19%	5,43 Mio. USD
6	Cresset Asset Management, LLC	0,78%	3,59 Mio. USD
7	Y.D. More Investments Ltd	0,59%	2,71 Mio. USD
8	Legato Capital Management LLC	0,49%	2,25 Mio. USD
9	Morgan Stanley - Brokerage Accounts	0,47%	2,16 Mio. USD
10	Eagle Global Advisors, LLC	0,46%	2,08 Mio. USD
11	ARK Investment Management LLC	0,36%	1,63 Mio. USD
12	SEI Investments Co	0,30%	1,37 Mio. USD
13	UBS Group AG	0,25%	1,15 Mio. USD
14	Sigma Planning Corp	0,25%	1,15 Mio. USD
15	Two Sigma Investments LLC	0,25%	1,14 Mio. USD
16	Royce & Associates, LP	0,24%	1,11 Mio. USD
17	JPMorgan Chase & Co	0,24%	1,10 Mio. USD
18	The Goldman Sachs Group Inc	0,23%	1,05 Mio. USD
19	Tidal Investments LLC.	0,22%	1,02 Mio. USD
20	Huntleigh Advisors Inc	0,22%	1,00 Mio. USD